The healthcare community is intrigued by retatrutide, a innovative dual GIP and GLP-1 receptor that’s showing impressive results in early trials . This compound works by imitating natural hormones to regulate appetite and promote feelings of fullness , ultimately resulting in noticeable fat loss . While presently under evaluation and not readily